Primary |
Postoperative Care |
15.0% |
Immunosuppression |
12.5% |
Non-hodgkin's Lymphoma |
10.0% |
Lung Transplant |
7.5% |
Chronic Obstructive Pulmonary Disease |
5.0% |
Hypertension |
5.0% |
Liver Transplant |
5.0% |
Pemphigus |
5.0% |
Psoriatic Arthropathy |
5.0% |
Rosacea |
5.0% |
Anaemia Haemolytic Autoimmune |
2.5% |
Dermatitis |
2.5% |
Dermatitis Atopic |
2.5% |
Duchenne Muscular Dystrophy |
2.5% |
Eczema |
2.5% |
Face Oedema |
2.5% |
Haemangioma |
2.5% |
Non-hodgkin's Lymphoma Stage Iv |
2.5% |
Polymorphic Eruption Of Pregnancy |
2.5% |
Polymyalgia Rheumatica |
2.5% |
|
Chorioretinopathy |
14.8% |
Vomiting |
11.1% |
Treatment Noncompliance |
7.4% |
Ulcerative Keratitis |
7.4% |
Conductive Deafness |
3.7% |
Infection |
3.7% |
Insulin Resistance |
3.7% |
Meningitis Cryptococcal |
3.7% |
Oligohydramnios |
3.7% |
Peptic Ulcer Perforation |
3.7% |
Peritonitis |
3.7% |
Postoperative Fever |
3.7% |
Pulmonary Embolism |
3.7% |
Rash Pustular |
3.7% |
Renal Failure |
3.7% |
Renal Failure Acute |
3.7% |
Restrictive Pulmonary Disease |
3.7% |
Retinal Pigment Epitheliopathy |
3.7% |
Sepsis |
3.7% |
Skin Test Positive |
3.7% |
|
Secondary |
Rheumatoid Arthritis |
16.7% |
Renal Transplant |
16.2% |
Multiple Myeloma |
14.8% |
Stem Cell Transplant |
9.3% |
Nephrotic Syndrome |
6.5% |
B-cell Lymphoma |
4.6% |
Systemic Lupus Erythematosus |
4.2% |
Acute Lymphocytic Leukaemia |
3.2% |
Peripheral T-cell Lymphoma Unspecified |
2.8% |
Asthma |
2.3% |
Drug Use For Unknown Indication |
2.3% |
Hypertension |
2.3% |
Lupus Nephritis |
2.3% |
Lymphoma |
2.3% |
Still's Disease Adult Onset |
2.3% |
Dermatomyositis |
1.9% |
Myasthenia Gravis |
1.9% |
Graft Versus Host Disease |
1.4% |
Heart And Lung Transplant |
1.4% |
Interstitial Lung Disease |
1.4% |
|
Thrombotic Microangiopathy |
12.8% |
Renal Vessel Disorder |
8.5% |
Respiratory Failure |
8.5% |
Erythema Multiforme |
6.4% |
Thrombocytopenia |
6.4% |
Vomiting |
6.4% |
Anaemia |
4.3% |
Gastritis Erosive |
4.3% |
Lymphocyte Count Decreased |
4.3% |
Nephrotic Syndrome |
4.3% |
Neutropenia |
4.3% |
Pneumocystis Jiroveci Pneumonia |
4.3% |
Sialoadenitis |
4.3% |
Stevens-johnson Syndrome |
4.3% |
Stomatitis |
4.3% |
Thrombosis |
4.3% |
Colitis Ischaemic |
2.1% |
Cytomegalovirus Infection |
2.1% |
Depression |
2.1% |
Gait Disturbance |
2.1% |
|
Concomitant |
Rheumatoid Arthritis |
28.5% |
Prophylaxis |
13.1% |
Constipation |
6.9% |
Nausea |
6.9% |
Hypertension |
5.4% |
Infection |
4.6% |
Pleural Mesothelioma Malignant Recurrent |
4.6% |
Bronchopulmonary Aspergillosis |
3.1% |
Epilepsy |
3.1% |
Interstitial Lung Disease |
3.1% |
Anaemia |
2.3% |
Cough |
2.3% |
Fungal Infection |
2.3% |
Hypokalaemia |
2.3% |
Lupus Nephritis |
2.3% |
Pain |
2.3% |
Supplementation Therapy |
2.3% |
Benign Prostatic Hyperplasia |
1.5% |
Cardiac Failure Chronic |
1.5% |
Cord Blood Transplant Therapy |
1.5% |
|
Shock |
17.1% |
Interstitial Lung Disease |
11.4% |
Death |
8.6% |
Nephrotic Syndrome |
5.7% |
Pyrexia |
5.7% |
Sepsis |
5.7% |
Staphylococcal Bacteraemia |
5.7% |
Vomiting |
5.7% |
Cardiac Failure |
2.9% |
Cerebral Haemorrhage |
2.9% |
Dengue Fever |
2.9% |
Drug Interaction |
2.9% |
Failure To Thrive |
2.9% |
Hepatic Function Abnormal |
2.9% |
Joint Arthroplasty |
2.9% |
Juvenile Arthritis |
2.9% |
Loss Of Consciousness |
2.9% |
Lung Infiltration |
2.9% |
Lymphangiosis Carcinomatosa |
2.9% |
Pain |
2.9% |
|
Interacting |
Localised Infection |
50.0% |
Rheumatoid Arthritis |
50.0% |
|
|